Cargando…
THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
Disclosure: Z. Shahidzadeh Yazdi: None. E.A. Streeten: Grant Recipient; Self; Regeneron Pharmaceuticals. H.B. Whitlatch: Grant Recipient; Self; Regeneron Pharmaceuticals. M.E. Montasser: Grant Recipient; Self; Regeneron Pharmaceuticals. A.L. Beitelshees: None. S.I. Taylor: Consulting Fee; Self; Ioni...
Autores principales: | Yazdi, Zhinoosossadat Shahidzadeh, Streeten, Elizabeth A, Whitlatch, Hilary B, Montasser, May E, Beitelshees, Amber L, Taylor, Simeon I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555310/ http://dx.doi.org/10.1210/jendso/bvad114.360 |
Ejemplares similares
-
Vitamin D deficiency increases vulnerability to canagliflozin-induced adverse effects on 1,25-dihydroxyvitamin D and PTH
por: Yazdi, Zhinous Shahidzadeh, et al.
Publicado: (2023) -
THU406 24-hydroxylase Deficiency, A Rare Cause Of Hypercalcemia
por: Hodge, Jordesha, et al.
Publicado: (2023) -
MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020) -
SAT-356 Reversible Suppression of Serum 1,25-Dihydroxyvitamin D in Williams Syndrome
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020) -
ODP125 Soft Bones in Crohn's: Tumor-induced osteomalacia and inflammatory bowel disease
por: Habbsa, Samima, et al.
Publicado: (2022)